Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications
Jean‐Pierre Changeux, Zahir Amoura, F.A. Rey, et al.
Comptes Rendus Biologies (2020) Vol. 343, Iss. 1, pp. 33-39
Open Access | Times Cited: 291

Showing 1-25 of 291 citing articles:

Collider bias undermines our understanding of COVID-19 disease risk and severity
Gareth J Griffith, Tim Morris, Matthew Tudball, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 763
COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-Chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?
Donato Gemmati, Barbara Bramanti, Maria Luisa Serino, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 10, pp. 3474-3474
Open Access | Times Cited: 370
Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people
Julia Hippisley‐Cox, Duncan Young, Carol Coupland, et al.
Heart (2020) Vol. 106, Iss. 19, pp. 1503-1511
Open Access | Times Cited: 350
Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation
Mary Hongying Cheng, She Zhang, Rebecca A. Porritt, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 41, pp. 25254-25262
Open Access | Times Cited: 320
Association of the COVID‐19 lockdown with smoking, drinking and attempts to quit in England: an analysis of 2019–20 data
Sarah E. Jackson, Claire Garnett, Lion Shahab, et al.
Addiction (2020) Vol. 116, Iss. 5, pp. 1233-1244
Open Access | Times Cited: 265
The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial
Carlos Chaccour, Aina Casellas, Andrés Blanco-Di Matteo, et al.
EClinicalMedicine (2021) Vol. 32, pp. 100720-100720
Open Access | Times Cited: 204
Addictions in the COVID-19 era: Current evidence, future perspectives a comprehensive review
Jasmina Mallet, Caroline Dubertret, Yann Le Strat
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 106, pp. 110070-110070
Open Access | Times Cited: 137
Impact of Tobacco Smoking on the Risk of COVID-19: A Large Scale Retrospective Cohort Study
N. Paleiron, Aurélie Mayet, Vanessa Marbac, et al.
Nicotine & Tobacco Research (2021) Vol. 23, Iss. 8, pp. 1398-1404
Open Access | Times Cited: 125
Multisystem Inflammatory Syndrome in Children and Long COVID: The SARS-CoV-2 Viral Superantigen Hypothesis
Magali Noval Rivas, Rebecca A. Porritt, Mary Hongying Cheng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 94
‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA
Peter Parry, Astrid Lefringhausen, Conny Turni, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2287-2287
Open Access | Times Cited: 51
Nicotinic acetylcholine receptors: Therapeutic targets for novel ligands to treat pain and inflammation
Arik J. Hone, J. Michael McIntosh
Pharmacological Research (2023) Vol. 190, pp. 106715-106715
Open Access | Times Cited: 49
Increased Risk of Hospitalization and Death in Patients with COVID-19 and Pre-existing Noncommunicable Diseases and Modifiable Risk Factors in Mexico
Diego Hernández-Galdamez, Miguel Ángel González-Block, Daniela Karola Romo-Dueñas, et al.
Archives of Medical Research (2020) Vol. 51, Iss. 7, pp. 683-689
Open Access | Times Cited: 136
Smoking, SARS-CoV-2 and COVID-19: A review of reviews considering implications for public health policy and practice
Emily J Grundy, Taiba Suddek, Filippos T Filippidis, et al.
Tobacco Induced Diseases (2020) Vol. 18, Iss. July
Open Access | Times Cited: 118
COVID-19 research: pandemic versus “paperdemic”, integrity, values and risks of the “speed science”
Ricardo Jorge Dinis‐Oliveira
Forensic Sciences Research (2020) Vol. 5, Iss. 2, pp. 174-187
Open Access | Times Cited: 117
Neurobiochemical Cross-talk Between COVID-19 and Alzheimer’s Disease
Mohammad Azizur Rahman, Kamrul Islam, Saidur Rahman, et al.
Molecular Neurobiology (2020) Vol. 58, Iss. 3, pp. 1017-1023
Open Access | Times Cited: 111
COVID-19, smoking and inequalities: a study of 53 002 adults in the UK
Sarah E. Jackson, Jamie Brown, Lion Shahab, et al.
Tobacco Control (2020) Vol. 30, Iss. e2, pp. e111-e121
Open Access | Times Cited: 104
Smoking and COVID-19: Adding Fuel to the Flame
Vivek K. Kashyap, Anupam Dhasmana, Andrew E. Massey, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6581-6581
Open Access | Times Cited: 101
Impact of Smoking Status on Disease Severity and Mortality of Hospitalized Patients With COVID-19 Infection: A Systematic Review and Meta-analysis
Αντώνιος Καρανάσος, Konstantinos Aznaouridis, George Latsios, et al.
Nicotine & Tobacco Research (2020) Vol. 22, Iss. 9, pp. 1657-1659
Open Access | Times Cited: 97
Tobacco Quit Intentions and Behaviors among Cigar Smokers in the United States in Response to COVID-19
Sarah D. Kowitt, Jennifer Cornacchione Ross, Kristen L Jarman, et al.
International Journal of Environmental Research and Public Health (2020) Vol. 17, Iss. 15, pp. 5368-5368
Open Access | Times Cited: 92
Lung innervation in the eye of a cytokine storm: neuroimmune interactions and COVID-19
Francesco De Virgiliis, Simone Di Giovanni
Nature Reviews Neurology (2020) Vol. 16, Iss. 11, pp. 645-652
Open Access | Times Cited: 89
Spatial and temporal trends in social vulnerability and COVID-19 incidence and death rates in the United States
Brian Neelon, Fedelis Mutiso, Noel T. Mueller, et al.
PLoS ONE (2021) Vol. 16, Iss. 3, pp. e0248702-e0248702
Open Access | Times Cited: 89
COVID-19 Susceptibility in Bronchial Asthma
Ilan Green, Eugene Merzon, Shlomo Vinker, et al.
The Journal of Allergy and Clinical Immunology In Practice (2020) Vol. 9, Iss. 2, pp. 684-692.e1
Open Access | Times Cited: 81
Implications for Neuromodulation Therapy to Control Inflammation and Related Organ Dysfunction in COVID-19
Marat Fudim, Yawar J. Qadri, Kamrouz Ghadimi, et al.
Journal of Cardiovascular Translational Research (2020) Vol. 13, Iss. 6, pp. 894-899
Open Access | Times Cited: 80
Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal?
David A. Jans, Kylie M. Wagstaff
Cells (2020) Vol. 9, Iss. 9, pp. 2100-2100
Open Access | Times Cited: 79
Tobacco smoking and COVID-19 pandemic: old and new issues. A summary of the evidence from the scientific literature.
Maria Sofia Cattaruzza, Vincenzo Zagà, Silvano Gallus, et al.
PubMed (2020) Vol. 91, Iss. 2, pp. 106-112
Closed Access | Times Cited: 77
Page 1 - Next Page

Scroll to top